CoChat

m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer

Open access
Zhao, Yueshui, Zhao, Qijie, Kaboli, Parham Jabbarzadeh, Shen, Jing, Li, Mingxing, Wu, Xu, Yin, Jianhua, Zhang, Hanyu, Wu, Yuanlin, Lin, Ling, Zhang, Lingling, Wan, Lin, Wen, Qinglian, Li, Xiang, Cho, Chi Hin, Yi, Tao, Li, Jing, Xiao, Zhangang · 2019 · Translational Oncology
Cited by 187

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Gene expression can be posttranscriptionally regulated by a complex network of proteins. N1-methyladenosine (m1A) is a newly validated RNA modification. However, little is known about both its influence and biogenesis in tumor development. METHODS: This study analyzed TCGA data of patients with five kinds of gastrointestinal (GI) cancers. Using data from cBioPortal, molecular features of the nine known m1A-related enzymes in GI cancers were investigated. Using a variety of bioinformatics approach, the impact of m1A regulators on its downstream signaling pathway was studied. To further confirm this regulation, the effect of m1A writer ALKBH3 knockdown was studied using RNA-seq data from published database. RESULTS: Dysregulation and multiple types of genetic alteration of putative m1A-related enzymes in tumor samples were observed. The ErbB and mTOR pathways with ErbB2, mTOR, and AKT1S1 hub genes were identified as being regulated by m1A-related enzymes. The expression of both ErbB2 and AKT1S1 was decreased after m1A writer ALKBH3 knockdown. Furthermore, Gene Ontology analysis revealed that m1A downstream genes were associated with cell proliferation, and the results showed that m1A genes are reliably linked to mTOR. CONCLUSION: This study demonstrated for the first time the dysregulation of m1A regulators in GI cancer and its signaling pathways and will contribute to the understanding of RNA modification in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tranon.2019.06.007

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 187

Metadata

Authors
Zhao, Y., Zhao, Q., Kaboli, P. J., Shen, J., Li, M., Wu, X., Yin, J., Zhang, H., Wu, Y., Lin, L., Zhang, L., Wan, L., Wen, Q., Li, X., Cho, C. H., Yi, T., Li, J., & Xiao, Z.
Venue
Translational Oncology
Publisher
Elsevier BV
Published
2019-10
Volume
12
Issue
10
Pages
1323-1333
ISSN
1936-5233 (ISSN-L)
OpenAlex
W2963513084
Cited by
187
References
62
FWCI
6.16
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer. https://app.cochat.ai/papers/10.1016/j.tranon.2019.06.007
The paper
Zhao, Y., Zhao, Q., Kaboli, P. J., Shen, J., Li, M., Wu, X., Yin, J., Zhang, H., Wu, Y., Lin, L., Zhang, L., Wan, L., Wen, Q., Li, X., Cho, C. H., Yi, T., Li, J., & Xiao, Z. (2019). m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer. Translational Oncology. https://doi.org/10.1016/j.tranon.2019.06.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.